Stock VAL VALIRX PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials ValiRx plc

Equities

VAL

GB00BLH13C52

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:14 2024-05-16 EDT 		5-day change 1st Jan Change
1.9 GBX 0.00% Intraday chart for ValiRx plc -38.71% -67.80%
05-16 EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target AN
05-15 Vertu Motors ups dividend as hails record revenue AN

Valuation

Fiscal Period: December 2018 2020 2021 2022 2023
Capitalization 1 4.936 12.65 23.58 9.107 2.515
Enterprise Value (EV) 1 4.877 12.65 22.99 7.969 7.59
P/E ratio -0.88 x -0.05 x - - -2.94 x
Yield - - - - -
Capitalization / Revenue - - - - 791 x
EV / Revenue - - - - 791 x
EV / EBITDA -1.31 x - - -4.33 x -3.69 x
EV / FCF -1.33 x - - - -0.34 x
FCF Yield -75.4% - - - -294%
Price to Book - - - - 0.43 x
Nbr of stocks (in thousands) 4,786 64,882 65,049 65,049 132,349
Reference price 2 1.031 0.1950 0.3625 0.1400 0.0190
Announcement Date 19-05-29 21-04-27 22-06-07 23-06-05 24-05-15
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2020 2021 2022 2023
Net sales 1 - - - - 0.0096
EBITDA 1 -3.723 - - -1.842 -2.056
EBIT 1 -3.866 - -1.678 -2.593 -2.299
Operating Margin - - - - -23,943.13%
Earnings before Tax (EBT) 1 -4.829 - - - -2.303
Net income 1 -4.299 -1.443 - - -2.038
Net margin - - - - -21,226.04%
EPS 2 -1.175 -3.810 - - -0.0201
Free Cash Flow 1 -3.678 - - - -2.1
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 19-05-29 21-04-27 22-06-07 23-06-05 24-05-15
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 0.06 - 0.59 1.14 1.8
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -3.68 - - - -2.1
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - - - 0.0400
Cash Flow per Share - - - - -
Capex 1 0.32 - - - 0.31
Capex / Sales - - - - -
Announcement Date 19-05-29 21-04-27 22-06-07 23-06-05 24-05-15
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VALIRX PLC Stock ValiRx plc
-67.80% 3.19M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+8.29% 113B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.21% 106B
ARGENX SE Stock argenx SE
+0.41% 22.27B
BIONTECH SE Stock BioNTech SE
-11.90% 22.22B
GENMAB A/S Stock Genmab A/S
-5.99% 19.43B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.36% 17.87B
BEIGENE, LTD. Stock BeiGene, Ltd.
-5.17% 17.24B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.70% 14.29B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.65% 12.52B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VAL Stock
  4. Financials ValiRx plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW